Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Shares Outstanding: 2022-2024

Historic Shares Outstanding for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $54.0 million.

  • Stoke Therapeutics' Shares Outstanding rose 4.12% to $55.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 4.12%. This contributed to the annual value of $54.0 million for FY2024, which is 17.67% up from last year.
  • Latest data reveals that Stoke Therapeutics reported Shares Outstanding of $54.0 million as of FY2024, which was up 17.67% from $45.9 million recorded in FY2023.
  • Over the past 5 years, Stoke Therapeutics' Shares Outstanding peaked at $54.0 million during FY2024, and registered a low of $39.4 million during FY2022.
  • In the last 3 years, Stoke Therapeutics' Shares Outstanding had a median value of $45.9 million in 2023 and averaged $46.5 million.
  • Data for Stoke Therapeutics' Shares Outstanding shows a peak YoY grew of 17.67% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Stoke Therapeutics' Shares Outstanding stood at $39.4 million in 2022, then climbed by 16.43% to $45.9 million in 2023, then increased by 17.67% to $54.0 million in 2024.